Factset Research Systems Inc: Form 10-Q for the period ended May 31, 2023
Filed with the SEC on Jul 3, 2023 and accepted by EDGAR at Jul 3, 2023, 07:48 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-05-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-03-01 to 2023-05-31 | $529.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2022-09-01 to 2023-05-31 | $1.55bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-03-01 to 2023-05-31 | $241.7m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2022-09-01 to 2023-05-31 | $709.5m | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2023-03-01 to 2023-05-31 | $115.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2022-09-01 to 2023-05-31 | $325.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-03-01 to 2023-05-31 | $172.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2022-09-01 to 2023-05-31 | $513.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-03-01 to 2023-05-31 | $16.4m | us-gaap:InterestExpense |
| Interest expense | 9 months2022-09-01 to 2023-05-31 | $49.6m | us-gaap:InterestExpense |
| Income tax | 3 months2023-03-01 to 2023-05-31 | $27.3m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2022-09-01 to 2023-05-31 | $73.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-03-01 to 2023-05-31 | $134.7m | us-gaap:NetIncomeLoss |
| Net income | 9 months2022-09-01 to 2023-05-31 | $403.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-03-01 to 2023-05-31 | $3.46 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2022-09-01 to 2023-05-31 | $10.35 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-03-01 to 2023-05-31 | $3.52 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2022-09-01 to 2023-05-31 | $10.54 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-03-01 to 2023-05-31 | 38,912,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2022-09-01 to 2023-05-31 | 38,936,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2022-09-01 to 2023-05-31 | $489.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2023-03-01 to 2023-05-31 | $26.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Capital expenditure | 9 months2022-09-01 to 2023-05-31 | $61.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2022-09-01 to 2023-05-31 | $101.4m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months2022-09-01 to 2023-05-31 | $67.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-05-31 | $486.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-05-31 | $844.3m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-05-31 | $4.00bn | us-gaap:Assets |
| Current liabilities | At period end2023-05-31 | $400.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-05-31 | $2.33bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-05-31 | $1.67bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2023-05-31 | $1.67bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001013237-23-000070. Last ingested by Listed: Oct 26, 2026, 08:25 ET. Listed shows no prices and gives no investment advice.